Leucine Medtech Profile
Key Indicators
- Authorised Capital ₹ 0.26 M
as on 07-07-2024
- Paid Up Capital ₹ 0.15 M
as on 07-07-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -28.90%
(FY 2023)
- Profit 133.16%
(FY 2023)
- Ebitda 133.96%
(FY 2023)
- Net Worth 2442.07%
(FY 2023)
- Total Assets 30.50%
(FY 2023)
About Leucine Medtech
The Corporate was formerly known as Leucine Nutrition Products Private Limited. The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.26 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Mustaq Bijral and Vivek Gera serve as directors at the Company.
- CIN/LLPIN
U15400RJ2015PTC047406
- Company No.
047406
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Sri Ganganagar, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Leucine Medtech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mustaq Bijral  | Director | 06-Jan-2020 | Current |
| Vivek Gera | Director | 22-Apr-2015 | Current |
Financial Performance of Leucine Medtech.
Leucine Medtech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.9% decrease. The company also saw a substantial improvement in profitability, with a 133.16% increase in profit. The company's net worth Soared by an impressive increase of 2442.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Leucine Medtech?
In 2023, Leucine Medtech had a promoter holding of 92.44% and a public holding of 7.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tnn Technologies Private LimitedActive 3 years 10 monthsMustaq Bijral and Vivek Gera are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Leucine Medtech?
Unlock and access historical data on people associated with Leucine Medtech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leucine Medtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leucine Medtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
